Tern – Fundraise For Talking Medicines: Good News?
By Nigel Somerville, the Deputy Sheriff of AIM | Wednesday 2 February 2022
Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.
AIM-listed jam-tomorrow investment company Tern plc (TERN) announced yesterday that investee Talking Medicines had raised £1.59 million from a fundraise – including £400,000 from Tern. The company trumpeted that the value of its investment had therefore headed north from £0.86 million to £1.79 million. Is it time for the TERNers to crack open the Ouzo?
Premium content is for paid subscribers only
ShareProphets is reader-supported journalism
Become a member starting at £6.99 per month for all articles, the Bearcast, and our seven year archive.